Skip to main content

WELLS FARGO & COMPANY/MN

Position in LNTH — Lantheus Holdings, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in LNTH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,364,992
+$8,457,702 QoQ
Shares Held
156,526
+33.3% QoQ
Ownership
0.240%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 466 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Derivatives in LNTH

reported options exposure · as of Dec 31, 2023
CallValue
$6,255,800
CallShares
100,900
PutValue
$15,221,000
PutShares
245,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. LNTH ranks #9 (3.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LNTH

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,364,992 156,526
2026-03-31 $8,907,290 117,433
2025-12-31 $11,040,377 165,896
2025-09-30 $7,681,189 149,760
2025-06-30 $15,335,569 187,339
2025-03-31 $14,120,181 144,674
2024-12-31 $25,043,519 279,941
2024-09-30 $28,983,437 264,086
2024-06-30 $19,008,093 236,743
2024-03-31 $14,057,649 225,862
2023-12-31 $26,766,268 431,714
2023-12-31 $15,221,000 245,500
2023-12-31 $6,255,800 100,900
2023-09-30 $7,390,239 106,365
2023-06-30 $6,942,028 82,722
2023-03-31 $8,256 100
2023-03-31 $3,312,140 40,118
2022-12-31 $974,609 19,125
2022-09-30 $3,197,200 45,460
2022-06-30 $1,707,666 25,862
2022-03-31 $3,837,572 69,383
2021-12-31 $2,396,770 82,962
2021-09-30 $1,716,886 66,857
2021-06-30 $1,767,660 63,953
2021-03-31 $761,283 35,624
2020-12-31 $2,052,366 152,140
2020-09-30 $2,374,103 187,380
2020-06-30 $1,829,769 127,956
2020-03-31 $1,794,999 140,674